Phased implementation of an antimicrobial stewardship program for a large community hospital system

Am J Infect Control. 2019 Jan;47(1):69-73. doi: 10.1016/j.ajic.2018.06.009. Epub 2018 Aug 3.

Abstract

Background: Antimicrobial stewardship is recommended as a crucial mechanism to reduce the emergence of antimicrobial resistance. The purpose of this article was to describe implementation of antimicrobial management programs (AMPs) across a large health system of community hospitals.

Methods: The initiative was structured in 4 phases. Although each phase was implemented sequentially, facilities could progress at their own pace. Phase goals needed to be met before moving to the next phase. The 4 phases included preparatory, foundational, clinical care optimization, and refinement. A survey was administered prior to the initiative in 2010, and modified surveys were administered in 2015 and 2017.

Results: Stewardship activities improved in most areas of the AMP initiative in 2015, with substantial improvement by 2017. Important changes included an increase in established programs, from 82% in 2010 to 88% and 96% in 2015 and 2017, respectively. Physician Champions increased from 73% in 2010 to 94% in 2017. Advances were made in the use of evidence-based treatment recommendations, antibiogram development, prospective audit and feedback for antimicrobials, tracking of antibiotic usage metrics, and a cost reduction of 40% from baseline.

Conclusion: A well-designed, phased approach to implementing AMP can help community hospitals and hospital systems recognize substantial clinical and financial benefits.

Keywords: Antibiotic; Antimicrobial; Antimicrobial management; Antimicrobial stewardship; Community hospital; Healthcare system; Physician champion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Antimicrobial Stewardship / methods*
  • Antimicrobial Stewardship / organization & administration*
  • Drug Utilization / standards*
  • Hospitals, Community*
  • Humans
  • Surveys and Questionnaires

Substances

  • Anti-Bacterial Agents